Target intelligence / Profile preview

RNA, U6 small nuclear 1025, pseudogene (RNU6-1025P)

Target
RNU6-1025P
Molecular classification
Other (pseudogene, noncoding RNA)
01

Overview

RNA, U6 small nuclear 1025, pseudogene (RNU6-1025P) is a noncoding RNA locus classified as a pseudogene in the genome, related by sequence to the highly conserved U6 small nuclear RNA (snRNA) but lacking protein-coding and canonical snRNA function. RNU6-1025P is a genomic pseudogene derived from the highly conserved U6 small nuclear RNA gene locus. U6 snRNA is an essential noncoding RNA involved in the spliceosome complex, mediating pre-mRNA splicing in eukaryotic nuclei. RNU6-1025P, however, is a pseudogene — it retains sequence similarity to U6 but has lost the capacity for normal snRNA function due to disabling mutations or truncations. Pseudogenes, including RNU6-1025P, are generally considered functionless copies or remnants of active genes, although in rare cases they may influence biological processes through regulatory RNA functions; no such role has been established for RNU6-1025P. This locus is not a drug target, does not encode a functional protein or RNA component, and is not associated with any known disease state or therapeutic intervention. It is important not to confuse RNU6-1025P with functionally active U6 snRNA, which is a central RNA component of the spliceosome complex. RNU6-1025P is a “processed pseudogene”—likely arising via retrotransposition—and annotated as such in genomic databases. There is no evidence that RNU6-1025P is transcribed, functions as an lncRNA, or acts as a biomarker or therapeutic target. In summary, RNU6-1025P is an inactive, non-protein-coding RNA pseudogene, related by sequence to U6 snRNA but not involved in splicing or disease biology, and is not considered a molecular target for drug discovery or therapy.

Other names
RNU6-1025PRNA, U6 small nuclear 1025, pseudogene
02

Biological functions

Other (no proven biological function; pseudogenes may sometimes have regulatory lncRNA roles, but no evidence exists specifically for RNU6-1025P)
03

Disease associations

Other (no direct implication in disease; pseudogenes can sometimes be dysregulated in disease or act as regulatory elements in rare cases, but no evidence for this locus)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1025, pseudogene (RNU6-1025P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1025, pseudogene (RNU6-1025P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call